Skip to main content

Table 3 Results of multivariate Cox proportional-hazards regression analyzing the effect of baseline variables on in-hospital death

From: Prognostic value of NT-proBNP in patients with severe COVID-19

Mode

HR (95%CI)

P

Not Adjusted NT-proBNP, per 100 pg/ml

1.369 (1.217–1.541)

< 0.001

Mode 1

 NT-proBNP, per 100 pg/ml

1.323 (1.119–1.563)

0.001

 Female vs. Male

1.077 (0.330–3.518)

0.902

 Age, per 10 years

1.176 (0.719–1.922)

0.518

Mode 2

 NT-proBNP, per 100 pg/ml

1.342 (1.185–1.520)

< 0.001

 HP, yes vs. no

1.613 (0.591–4.406)

0.351

 CHD, yes vs. no

1.219 (0.422–3.521)

0.714

Mode 3

 NT-proBNP, per 100 pg/ml

1.360 (1.177–1.572)

< 0.001

 MYO, per 1 ng/ml

1.001 (0.996–1.005)

0.773

 CK-MB, per 1 μg/L

1.119 (0.905–1.385)

0.299

 Hs-TnI, per 0.1 ng/ml

1.031 (0.574–1.855)

0.918

Mode 4

 NT-proBNP, per 100 pg/ml

1.373 (1.188–1.586)

< 0.001

 Urea, per 1 mmol/L

1.041 (0.936–1.158)

0.460

 Creatinine, per 1 umol/L

0.999 (0.974–1.025)

0.957

Mode 5

 NT-proBNP, per 100 pg/ml

1.248 (1.097–1.419)

0.001

 WBC, per 1 × 109/L

1.099 (1.015–1.190)

0.021

 LYM, per 1 × 109/L

0.163 (0.035–0.761)

0.021

Mode 6

 NT-proBNP, per 100 pg/ml

1.230 (1.003–1.509)

0.047

 WBC, per 1 × 109/L

1.036 (0.903–1.189)

0.611

 LYM, per 1 × 109/L

0.201 (0.033–1.221)

0.081

 CRP, per 1 mg/L

1.011 (0.999–1.023)

0.066

Mode 7

 NT-proBNP, per 100 pg/ml

1.200 (1.045–1.380)

0.010

 WBC, per 1 × 109/L

1.088 (0.016–1.164)

0.016

 LYM, per 1 × 109/L

0.151 (0.029–0.778)

0.024

 PCT, per 0.1 ng/ml

1.110 (1.010–1.220)

0.030

  1. Abbreviations: NT-proBNP N-terminal pro-brain natriuretic peptide, HP Hypertension, CHD Coronary heart disease, MYO Myoglobin, CK-MB Creatine kinase-MB, Hs-TnI High-sensitivity troponin-I, WBC White blood cell, LYM Lymphocytes, CRP C-reactive protein, PCT Procalcitonin, HR Hazards ratio; 95%CI 95% confidence interval